CLINICAL TRIALS, STUDIES, REGISTRIES, DATA

Medical device and technology company Lazurite® announced that a new article just published in the Journal of Orthopaedic Experience & Innovation provides key support for the usability of the company’s ArthroFree® wireless surgical camera.

Based on NAPT member survey data and other sources, “Temporal Evolution and Diagnostic Diversification of Patients Receiving Proton Therapy in the United States: A Ten-Year Trend Analysis (2012-21) from the National Association for Proton Therapy” largely debunks the misperception that proton therapy is used primarily as a treatment for prostate cancer.

“BENEFIT-01 Study was the first in a series of studies that speaks to our commitment to advancing and sharing the science behind SCS. It’s exciting to see these learnings realized as patients experience the positive impact of RESONANCE™ stimulation with our Prospera™ SCS system,” said Todd Langevin.

Sensorion notes This gene therapy for patients suffering from otoferlin deficiency has been developed in the framework of RHU AUDINNOVE, a consortium composed of Sensorion with the Necker Enfants Malades Hospital, the Institut Pasteur, and the Fondation pour l’Audition. The project is partially financed by the French National Research Agency, through the “investing for the future” program (ref: ANR-18-RHUS-0007).

The Orlucent system will be the first to provide clinicians with a noninvasive direct measure of early intra-cellular activity and shows promise to transform the landscape of identifying melanoma at its earliest stage.